← Eichor
Study identifier: NCT06459271 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Feasibility of CALM in Patients With Ovarian Cancer

Condition: Patient Satisfaction · Ovarian Cancer  ·  Sponsor: University Health Network, Toronto

PhaseNA
Planned participants50
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this feasibility trial is to determine the feasibility and acceptability of implementing a brief evidence-based psychotherapeutic intervention, Managing Cancer And Living Meaningfully (CALM), at the time of a new diagnosis and recurrence of ovarian cancer (OC). The main questions are: 1. Is it feasible and acceptable to implement CALM for patients with newly diagnosed or recently recurred advanced OC 2. What are the prevalence and correlates of traumatic stress symptoms at baseline in patients with newly diagnosed or recently recurred advanced OC Participants will be asked to complete questionnaires at baseline and at 3 and 6 months following a diagnosis or recurrence of stage III or IV OC. Participants will also be invited to participate in 3-6 sessions of CALM therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Megan A George, BSc  ·  6475463114  ·  megan.george@uhn.ca

Anne Rydall, MSc  ·  416-910-7349  ·  anne.rydall@uhn.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Princess Margaret Cancer CentreToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06459271